Thymia, a London, UK-based mental health technology company, raised a $2.7 million seed round to expand into new markets and grow its capabilities.
The round was led by Kodori Ventures, with participation from Entrepreneur First, Syndicate Room’s Access, Calm/Storm and Form Ventures, and investors Amanda M Cardinale and Nadav Rosenberg. It is also currently fundraising through round Crowdcube.
Thymia is taking an AI approach to diagnosing mental health symptoms and treatment plans through gamified AI tools.
Using its proprietary data set, which it claims is one of the largest in the world with over one billion data points collected from over 5000 individuals with mental health issues such as depression, generalized anxiety, and ADHD, the UK health tech start-up claims its tool can give a ‘more objective and empirical’ mental health assessment.
"By combining cutting-edge neuroscience and ethical, explainable AI, we have built a tool that can help people get an accurate diagnosis and effective treatment plan in place faster than ever before," says Thymia CEO Dr. Emilia Molimpakis.
Company: Thymia Limited
Round: Seed Round
Funding Month: July 2023
Lead Investors: Kodori Ventures
Additional Investors: Entrepreneur First, Syndicate Room’s Access, Calm/Storm, Form Ventures, Amanda M Cardinale, and Nadav Rosenberg
Company Website: https://thymia.ai/
Software Category: AI Mental Health Assessment
About the Company: Thymia is a mental health technology company that developed an AI-based video game that is meant to provide faster, more accurate, and objective mental health assessments. Its video games analyze speech patterns, facial expressions, and behavior to objectively measure mental health symptoms, starting with depression. The platform offers continuous monitoring for patients and clinicians to understand the conditions and treatment in real-time. The company’s mission is to make mental health as objectively measurable and monitorable as physical health.